"Piracetam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound suggested to be both a nootropic and a neuroprotective agent.
| Descriptor ID |
D010889
|
| MeSH Number(s) |
D02.065.064.650 D02.241.081.018.110.650 D03.383.773.812.555
|
| Concept/Terms |
Piracetam- Piracetam
- Pyracetam
- Pirazetam
- 2-Pyrrolidone-N-Acetamide
- Pyramem
Sinapsan- Sinapsan
- Piracetam-RPh
- Piracetam RPh
|
Below are MeSH descriptors whose meaning is more general than "Piracetam".
Below are MeSH descriptors whose meaning is more specific than "Piracetam".
This graph shows the total number of publications written about "Piracetam" by people in this website by year, and whether "Piracetam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Piracetam" by people in Profiles.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2018 10 19; 10:CD003426.
-
Mintzer S, Miller R, Shah K, Chervoneva I, Nei M, Skidmore C, Sperling MR. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. Epilepsy Behav. 2016 05; 58:127-32.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2016 Mar 04; 3:CD003426.
-
Deeb S, McKeown DA, Torrance HJ, Wylie FM, Logan BK, Scott KS. Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases. J Anal Toxicol. 2014 Oct; 38(8):485-94.
-
Maitre NL, Smolinsky C, Slaughter JC, Stark AR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013 Nov; 33(11):841-6.
-
Riviello JJ, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, Glauser T, Shutter L, Treiman DM, Vespa PM, Bell R, Brophy GM. Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2012 Jul 11; (7):CD003426.
-
Sharpe CM, Capparelli EV, Mower A, Farrell MJ, Soldin SJ, Haas RH. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Res. 2012 Jul; 72(1):43-9.
-
Farooque P, Goraya J, Valencia I, Carvalho KS, Hardison HH, Legido A, Khurana DS. Early-onset childhood absence epilepsy: is it a distinct entity? Epileptic Disord. 2011 Dec; 13(4):411-6.
-
Guilhoto LM, Loddenkemper T, Vendrame M, Bergin A, Bourgeois BF, Kothare SV. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav. 2011 Feb; 20(2):334-7.